To include your compound in the COVID-19 Resource Center, submit it here.
The partners expanded a February deal to give Yakult Honsha exclusive rights to cancer candidate PR610 in Japan. The partners
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury